Matt Foehr

(Mr. Matthew Foehr)

Currently holds positions in Viking Therapeutics Inc, Qualigen Therapeutics Inc and Ligand Pharmaceuticals Inc

Positions

Position Company Period
Director Viking Therapeutics Inc May 1, 2014 -
Independent Director Qualigen Therapeutics Inc Feb. 1, 2015 -
President, Chief Operating Officer Ligand Pharmaceuticals Inc Jan. 27, 2015 -
Chief Operating Officer, Executive Vice President Ligand Pharmaceuticals Inc April 18, 2011 - Jan. 27, 2015
Matt Foehr's trades of OmniAb Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
S Sale
19,382 -0.5%
2.00
USD 38,764 		19,382 -0.5% 2.00 USD 38,764
2025-02-19 2025-02-19
US OmniAb Inc (OABI)
S Sale
19,522 -0.5%
3.67
USD 71,646 		19,522 -0.5% 3.67 USD 71,646
2025-02-19 2025-02-18
US OmniAb Inc (OABI)
S Sale
13,964 -0.4%
3.68
USD 51,388 		13,964 -0.4% 3.68 USD 51,388
2025-01-22 2025-01-21
US OmniAb Inc (OABI)
S Sale
41,811 -1.1%
3.24
USD 135,468 		41,811 -1.1% 3.24 USD 135,468
2024-12-10 2024-12-09
US OmniAb Inc (OABI)
S Sale
13,634 -0.4%
4.13
USD 56,308 		13,634 -0.4% 4.13 USD 56,308
2024-05-28 2024-05-24
US OmniAb Inc (OABI)
B Purchase
240,000 +7.3%
4.42
USD 1,059,840 		240,000 +7.3% 4.42 USD 1,059,840
2024-03-25 2024-03-22
US OmniAb Inc (OABI)
B Purchase
225,000 +8.4%
5.19
USD 1,167,750 		225,000 +8.4% 5.19 USD 1,167,750
2023-12-13 2023-12-12
US OmniAb Inc (OABI)
B Purchase
200,000 +8.2%
5.05
USD 1,010,000 		200,000 +8.2% 5.05 USD 1,010,000
2023-11-13 2023-11-10
US OmniAb Inc (OABI)
B Purchase
95,000 +4.1%
4.27
USD 405,517 		95,000 +4.1% 4.27 USD 405,517
2023-08-15 2023-08-14
US OmniAb Inc (OABI)
B Purchase
45,000 +2.0%
5.48
USD 246,600 		45,000 +2.0% 5.48 USD 246,600
2023-06-12 2023-06-09
US OmniAb Inc (OABI)
B Purchase
115,000 +4.7%
4.52
USD 519,800 		115,000 +4.7% 4.52 USD 519,800
2023-05-15 2023-05-12
US OmniAb Inc (OABI)
B Purchase
440,000 +22.0%
3.40
USD 1,496,000 		440,000 +22.0% 3.40 USD 1,496,000
2022-12-14 2022-12-12
US OmniAb Inc (OABI)
B Purchase
150,000 +8.9%
3.77
USD 564,765 		150,000 +8.9% 3.77 USD 564,765
2022-12-01 2022-11-30
US OmniAb Inc (OABI)
B Purchase
300,000 +21.3%
3.39
USD 1,016,340 		300,000 +21.3% 3.39 USD 1,016,340
2022-11-09 2022-11-09
US OmniAb Inc (OABI)
B Purchase
100,000 +7.7%
2.76
USD 276,160 		100,000 +7.7% 2.76 USD 276,160
2022-05-13 2022-05-13
B Purchase
2,500 +1.5%
82.76
USD 206,910 		2,500 +1.5% 82.76 USD 206,910
2022-05-03 2022-05-02
B Purchase
45,000 +67.9%
2.47
USD 111,195 		45,000 +67.9% 2.47 USD 111,195
2021-11-12 2021-11-11
S Sale
11,160 -6.3%
163.02
USD 1,819,255 		11,160 -6.3% 163.02 USD 1,819,255
2021-08-05 2021-08-04
S Sale
8,840 -5.1%
109.67
USD 969,507 		8,840 -5.1% 109.67 USD 969,507
2021-06-10 2021-06-10
B Purchase
20,000 +43.2%
5.69
USD 113,800 		20,000 +43.2% 5.69 USD 113,800
2021-02-05 2021-02-04
S Sale
44,547 -20.9%
176.86
USD 7,878,582 		44,547 -20.9% 176.86 USD 7,878,582
2020-08-25 2020-08-24
PS Planned sale
78 -0.1%
110.89
USD 8,649 		78 -0.1% 110.89 USD 8,649
2020-08-25 2020-08-21
PS Planned sale
7,225 -4.4%
112.88
USD 815,541 		7,225 -4.4% 112.88 USD 815,541
2020-02-27 2020-02-27
PS Planned sale
7,225 -4.5%
110.00
USD 794,750 		7,225 -4.5% 110.00 USD 794,750
2020-02-18 2020-02-14
PS Planned sale
7,225 -4.4%
95.84
USD 692,467 		7,225 -4.4% 95.84 USD 692,467
2016-11-15 2016-11-15
B Purchase
13,000 +49.5%
1.21
USD 15,678 		13,000 +49.5% 1.21 USD 15,678
2015-05-05 2015-05-04
B Purchase
6,250 +inf%
8.00
USD 50,000 		6,250 +inf% 8.00 USD 50,000
// ... existing code ... // ... rest of the file ...